显微镜下多血管炎合并间质性肺病及其急性加重的临床意义
MPA-ILD组死亡率高于MPA-non-ILD组,匹配后亦高于ILD alone组;1年AE累积发生率分别为7.5%和5.2%(P=.75)。%FVC较低独立关联更高死亡率和AE发生率,病程中发生AE与更短生存强相关(HR 17.1)。
要点
- MPA-ILD是预后不良的独特表型,死亡率高于MPA-non-ILD和MPO-ANCA阴性ILD。
- 较低%FVC是MPA-ILD死亡率和AE发生率的独立预后因素。
- 病程中发生AE与更短生存强相关(HR 17.1)。
核心结论
- MPA-ILD代表一种预后不良的独特表型。
- 较低%FVC是独立预后因素,且低%FVC患者有发生AE的风险。
- AE是强烈的预后决定因素,需建立MPA-ILD和AE的特异性管理。
研究设计与样本
- 按年龄、性别和胸部高分辨率CT模式匹配80例MPA-ILD与80例MPO-ANCA阴性特发性间质性肺炎(ILD alone)患者。
主要发现
- MPA-ILD组男性及吸烟者比例更高,死亡率高于MPA-non-ILD组。
- 匹配的MPA-ILD组死亡率高于匹配的ILD alone组。
- 匹配的MPA-ILD与ILD alone组AE发生率无显著差异(1年AE累积发生率7.5%和5.2%,P=.75)。
- MPA-ILD组中较低%FVC独立关联更高死亡率(HR 0.96每1%增加,P<.01)和更高AE发生率(HR 0.96每1%增加,P=.01)。
- 多变量Cox回归(含时间依赖协变量)显示病程中发生AE与更短生存强相关(HR 17.1,P<.001)。
关键数值与推荐
- 1年AE累积发生率:匹配MPA-ILD组7.5%,匹配ILD alone组5.2%(P=.75)。
- %FVC每增加1%,死亡率HR 0.96(P<.01),AE发生率HR 0.96(P=.01)。
- 发生AE与更短生存的HR 17.1(P<.001)。
临床怎么用
- 对MPA-ILD患者应评估%FVC以识别死亡和AE高风险者。
- 病程中需警惕AE发生,因其与极差生存相关。
- MPA-ILD及AE的特异性管理方案尚待建立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Presence of interstitial lung disease (ILD) is thought to be associated with mortality in microscopic polyangiitis (MPA); however, evidence on MPA-ILD remains lacking. Acute exacerbation (AE) refers to rapidly progressive, fatal respiratory deterioration that may develop in patients with various ILDs. No study has investigated the clinical significance of AE in MPA-ILD. RESEARCH QUESTION: We aimed to determine the clinical picture and prognostic factors, the incidence of AE, and the risk factors in patients with MPA-ILD. STUDY DESIGN AND METHODS: Eighty-four consecutive patients with MPA-ILD and 95 patients with MPA-non-ILD were analyzed. We also compared 80 patients with MPA-ILD and 80 patients with idiopathic interstitial pneumonia without myeloperoxidase-antineutrophil cytoplasmic antibody positivity (ILD alone), who were matched for age, sex, and chest high-resolution CT scan pattern. RESULTS: The MPA-ILD group had a higher frequency of men and smokers and was associated with higher mortality than the MPA-non-ILD group. The matched MPA-ILD group had a higher mortality rate than the matched ILD alone group. There was no significant difference in AE incidence between the matched MPA-ILD and ILD alone groups (1-year AE cumulative incidence rate, 7.5% and 5.2%, respectively; P = .75). In the MPA-ILD group, a lower percent predicted FVC (%FVC) was independently associated with a higher mortality rate (hazard ratio [HR], 0.96 per 1% increase; P < .01) and a higher AE incidence rate (HR, 0.96 per 1% increase; P = .01). On multivariable Cox regression analysis with time-dependent covariates, developing AE during their clinical course was strongly associated with shorter survival (HR, 17.1; P < .001). INTERPRETATION: MPA-ILD represented a distinct phenotype with poor prognosis. Lower %FVC was an independent prognostic factor. Patients with lower %FVC had a risk of developing AE, which was a strong prognostic determinant. The specific management for MPA-ILD and AE should be established.
引用
- Hozumi H, Kono M, Hasegawa H, et al. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis. Chest. 2021. PMID: 33571506. doi:10.1016/j.chest.2021.01.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。